“Real Men, Real Depression” Marketing Masquerading as Medical News_Newsweek

The pharmaceutical industry’s latest antidepression drug marketing campaign is being launched with collaboration of the National Institute of Mental Health (NIMH) “Real Men, Real Depression campaign http://menanddepression.nimh.nih.gov/infopage.asp?ID=1 Continue reading →

4-year old Rebecca Riley,a Casualty of Psychiatric “Treatment”_BostonGlobe_NYT

“To me one of the miracle of children’s brains is that we don’t see more harm from these treatments.” Continue reading →

Op Ed: Psychiatry on the Ropes–WP / Evidence-based Psychiatry– Multi-Discipline Conference_ NYC

Op Ed: Psychiatry on the Ropes–WP / Evidence-based Psychiatry– Multi-Discipline Conference_ NYC Mon, 4 Oct 2004 An Op Ed article in The Washington Post by Shannon Brownlee (below) nails the elite procurers of psychotropic drugs who have long denied the ominous signals . . . Continue reading →

Pediatric Cardiologist Explains: The crucial health stat you’ve never heard of_Slate

Dr. Sanghavi provides us with a statistical reality-check by which to gauge for ourselves whether or not we should–or need not–take a  octor’s advice about starting a medical treatment for a speculated risk–rather than evidence of illness. Continue reading →

$29 Million Donations Tie Drug Firms and Nonprofits_Philadelphia Inquirer

An investigative report in The Philadelphia Inquirer examined pharmaceutical company ties to six, tax exempt organziations that identify themselves as “patient advocacy” groups, "Each a leading advocate for patients in a disease area.” 
Continue reading →

Shame on TIME Magazine–College Suicide Story is a Big Pharma Infomercial

A feature article in the current issue of TIME Magazine, “When Colleges Go On Suicide Watch” is a blatant example of an “infomercial” that extends pharmaceutical compay advertising pages into the news pages in TIME magazine.
Continue reading →

Yale-Lilly Experiment: Adolescents Rx Toxic Drug for Presumed Mental Illness They Do Not Have

When the Times refers to an experiment as "bold and controversial" the reporter is sanitizing the fact that the experiment is UNETHICAL—it violates medicine’s cardinal rule "First, do no harm."
Continue reading →

Glaxo denies “disease mongering”_Selling Bipolar questioned_PLoS

Under the influence of pharmaceutical companies, physicians anhd drug companies engage in "disease mongering."  Below is a critique of Dr. David Healy’s essay: Dr. Nassir Ghaemi who argues for the legitimacy of bipolar diagnosis. Continue reading →